China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.15
-0.07 (-1.34%)
May 8, 2026, 4:08 PM HKT

HKG:3320 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15,84416,42524,65115,22414,267
Short-Term Investments
11,9669,2237,5817,5079,766
Trading Asset Securities
103.14----
Cash & Short-Term Investments
27,91325,64832,23122,73124,034
Cash Growth
8.83%-20.43%41.79%-5.42%57.29%
Accounts Receivable
106,421101,67095,69584,81878,175
Other Receivables
8,4138,6576,9126,8457,612
Receivables
114,834110,327102,60791,66385,787
Inventory
43,27137,05331,87526,54724,186
Prepaid Expenses
4,0164,0764,7974,9533,506
Restricted Cash
----10.39
Other Current Assets
11,6738,7427,0576,3666,356
Total Current Assets
201,707185,846178,568152,259143,879
Property, Plant & Equipment
32,41125,90725,04321,69820,398
Long-Term Investments
7,1866,1436,8786,6226,388
Goodwill
24,34222,36921,45420,40920,287
Other Intangible Assets
8,2296,9486,5366,3596,149
Long-Term Deferred Tax Assets
2,3751,9691,7731,4351,067
Long-Term Deferred Charges
2,9731,5601,4811,2061,184
Other Long-Term Assets
6,5887,0185,0375,5463,146
Total Assets
285,811257,760246,770215,534202,497
Accounts Payable
64,78758,78654,45148,85342,673
Accrued Expenses
5,3114,7344,2215,3604,226
Short-Term Debt
363.72--10,16710,018
Current Portion of Long-Term Debt
49,83644,85345,76035,94138,259
Current Portion of Leases
492.94520.27463.53495.95475.61
Current Income Taxes Payable
917.9954.9730.03667.3728.63
Current Unearned Revenue
4,1424,2254,0233,5382,898
Other Current Liabilities
16,35918,14924,58516,74715,854
Total Current Liabilities
142,209132,222134,233121,770115,132
Long-Term Debt
21,34722,86415,0929,0425,850
Long-Term Leases
730.03768.14844.89770.27759.16
Long-Term Unearned Revenue
781.4713.72788.58775.14725.69
Pension & Post-Retirement Benefits
744.51773.54761.7828.95886.72
Long-Term Deferred Tax Liabilities
2,1311,9151,7181,5871,601
Other Long-Term Liabilities
412.36416.48356.96203.29161.17
Total Liabilities
168,355159,673153,795134,977125,116
Common Stock
24,63024,63024,63024,63022,193
Retained Earnings
34,83731,56729,70526,73123,134
Comprehensive Income & Other
-8,059-7,953-8,376-7,804-3,794
Total Common Equity
51,40848,24445,96043,55741,533
Minority Interest
66,04749,84347,01537,00035,848
Shareholders' Equity
117,45698,08792,97580,55777,381
Total Liabilities & Equity
285,811257,760246,770215,534202,497
Total Debt
72,77069,00562,16156,41655,362
Net Cash (Debt)
-44,857-43,357-29,930-33,685-31,328
Net Cash Per Share
-7.14-6.90-4.76-5.36-4.99
Filing Date Shares Outstanding
6,2836,2836,2836,2836,283
Total Common Shares Outstanding
6,2836,2836,2836,2836,283
Working Capital
59,49853,62444,33530,48928,747
Book Value Per Share
8.187.687.326.936.61
Tangible Book Value
18,83718,92817,96916,78915,098
Tangible Book Value Per Share
3.003.012.862.672.40
Buildings
20,69417,26416,12413,50712,991
Machinery
15,83413,55712,51110,5569,366
Construction In Progress
2,5211,5051,3391,930972.25
Leasehold Improvements
1,2961,059960.31741.77660.19
Source: S&P Global Market Intelligence. Standard template. Financial Sources.